If you've ever struggled with persistent acne, you've probably heard explanations like "it's hormones," "it's stress," or "it's your diet." And while those factors do play a role, brand-new research is revealing something much deeper — your acne may be rooted in the same biological processes that drive diseases like Crohn's disease and ulcerative colitis. In other words: your skin and your gut may be more connected than anyone realized.
What Is Inflammatory Bowel Disease?
Before we dive into the research, a quick primer. Inflammatory bowel disease — or IBD — is an umbrella term for two chronic conditions that cause inflammation in the digestive tract:
- Crohn's disease — can affect any part of the digestive system, from mouth to intestines
- Ulcerative colitis — primarily affects the large intestine (colon)
Symptoms can include persistent stomach pain, diarrhea, fatigue, and weight loss. IBD affects nearly 3 million Americans and, like acne, tends to flare up and calm down over time. What you may not know is that researchers have long noticed these two conditions seem to occur together more often than chance would predict — and now we finally have genetic evidence explaining why.
The Study: What Scientists Found
A major new study published in the Journal of Investigative Dermatology (April 2026) analyzed the DNA of more than 34,000 people with acne and over 30,000 people with IBD — one of the largest genetic analyses ever conducted on the connection between these two conditions.
Here's the headline finding, translated into plain English:
About 1 in 4 genetic variants linked to acne also contribute to IBD risk.
Researchers identified 36 shared genetic regions — areas of DNA that appear to influence both conditions. Most of these regions had never previously been linked to acne at all.
What makes this particularly compelling is that many of the shared genetic variants had what scientists call "concordant effects" — meaning they increase the risk of both acne and IBD in the same direction. This is strong evidence of a real biological relationship, not just a statistical coincidence.
"But Isn't This Just From Acne Medication?"
That's exactly what researchers asked — and this study directly addresses it.
For years, doctors had noticed that some patients on isotretinoin (commonly known as Accutane) developed IBD symptoms. The longstanding assumption was that the drug — not the acne itself — was causing gut problems. This led to significant concern and legal battles around isotretinoin.
This new genetic research tells a different story. The shared genetic variants were found regardless of treatment history, pointing to a common underlying biology between acne and IBD — not a medication side effect. In other words, people with acne may already carry a biological predisposition toward gut inflammation, independent of any treatment they take.
This is actually reassuring for patients considering isotretinoin: the acne-IBD connection appears to exist in the biology of the disease itself, not as a consequence of treating it.
The Immune System: Where Acne and IBD Collide
So what's actually happening under the surface? The answer lies in your immune system — specifically, white blood cells called T cells that regulate inflammation throughout your body.
When the researchers mapped where these shared genetic signals were most active, they found them concentrated in:
- Immune and blood tissues (like the spleen)
- The skin
- The gastrointestinal (gut) tract
Think of it this way: when these T cells don't function properly — when the immune system becomes overactive or dysregulated — inflammation can break out in multiple places at once. For some people, that means inflamed, acne-prone skin and an inflamed digestive tract.
The study specifically highlighted CD4+ T cells and regulatory T cells — two types of immune cells that help control inflammation but can become overactive in chronic disease. This gives researchers a much clearer picture of the "who" and "where" behind this connection.
The JAK-STAT Pathway: A Shared Switch
One biological pathway stood out above all others in this research: something called JAK-STAT signaling.
Think of JAK-STAT as a communication system inside your cells — a signal relay that tells your immune system when to ramp up inflammation and when to stand down. When this system is overactive, chronic inflammation can result in multiple organs simultaneously.
Here's why this matters clinically:
- Medications called JAK inhibitors are already used to treat IBD — they calm this overactive signaling pathway
- Acne-like skin eruptions have been reported as a side effect in some patients on JAK inhibitors — suggesting this pathway directly influences skin
- Early research points to increased JAK activity specifically in active acne lesions
This creates a fascinating picture: the same biological "switch" appears to be involved in driving both acne and IBD. Researchers believe this could eventually open the door to treatments that address both conditions through a shared mechanism.
Chemical Messengers: More Overlap Than We Knew
The study also found overlap in cytokine pathways — cytokines being the chemical messengers your immune system uses to turn inflammation on or off. Here's what was found, in plain terms:
| Chemical Messenger | What It Does |
|---|---|
| IL-12 & IL-23 | Drive the type of immune activation seen in both IBD and inflammatory acne |
| IL-13 | Affects how skin cells grow and renew — important for the skin barrier |
| IL-10 | An anti-inflammatory signal — when it's reduced, inflammation in both the gut and skin can increase |
Many of these cytokines are already targets for IBD medications. Researchers suggest they may eventually become targets for severe or treatment-resistant acne as well.
The Gut-Skin Axis: What It Means for You
The concept of the gut-skin axis — the bidirectional biological relationship between your digestive system and your skin — has been gaining traction in dermatology for years. This study gives it some of the strongest genetic evidence yet.
What this means in practice:
- If you have acne and GI symptoms (bloating, irregular bowel movements, persistent stomach pain), it's worth mentioning both to your dermatologist
- Acne may be a visible signal of systemic — whole-body — inflammation, not just a localized skin issue
- Addressing inflammation from the inside (through diet, gut health, and targeted therapies) may complement topical and oral acne treatments
This doesn't mean every person with acne has gut disease, or vice versa. But it does mean your dermatologist can think about your skin as part of a broader picture of your health — which often leads to better, more targeted treatment outcomes.
Does This Change How Acne Should Be Treated Right Now?
In the short term, no — the researchers are clear that standard acne treatments should not change based on this research alone. Benzoyl peroxide, retinoids, antibiotics, hormonal therapies, and isotretinoin all remain effective and appropriate.
But the longer-term implications are genuinely exciting. As science maps the genetic and immune overlaps between skin and gut conditions, we may eventually see:
- More personalized, pathway-based acne therapies — targeting the specific immune signals driving someone's particular type of acne
- Greater collaboration between dermatologists and gastroenterologists for patients with overlapping symptoms
- New treatments that address shared inflammatory drivers in both the skin and digestive tract simultaneously
Frequently Asked Questions
Does having acne mean I'll get inflammatory bowel disease?
No. Sharing some genetic variants does not mean one condition causes the other, or that you'll develop both. It simply means there is a biological relationship worth understanding. Many people have acne and never develop IBD, and vice versa.
Should I get tested for IBD if I have acne?
Not based on acne alone. However, if you have acne along with persistent GI symptoms — ongoing stomach pain, diarrhea, blood in stool, or unexplained fatigue — it's worth discussing with your doctor or dermatologist.
Is isotretinoin (Accutane) still safe for acne?
Yes. This study actually helps clarify that isotretinoin is not the primary driver of the acne-IBD connection — the link exists in the shared biology of both conditions. Your dermatologist can discuss whether isotretinoin is appropriate for your specific situation.
What is the gut-skin axis?
The gut-skin axis refers to the bidirectional biological relationship between your digestive system and your skin. Inflammation, immune activity, and the microbiome all play roles in how each system affects the other — and this study provides new genetic evidence that this connection is real.
Can diet changes help both acne and gut health?
Some evidence suggests that anti-inflammatory diets, probiotics, and reducing high-glycemic foods may support both gut and skin health. This is an active area of research. Talk to your dermatologist about whether dietary adjustments make sense alongside your current acne treatment plan.
The Bottom Line
Acne is increasingly understood as a manifestation of systemic inflammation — not just a surface-level skin problem. This landmark genetic study reveals that acne and IBD share a surprising amount of biological real estate: the same immune cells, the same signaling pathways, and now, the same genes.
While more research is needed — especially across more diverse populations — these findings represent a major step toward understanding acne as a whole-body condition. That shift in understanding is how we get to better, more targeted treatments in the years ahead.
Ready to take a comprehensive approach to your acne? The board-certified dermatologists at Dermatology of Seattle look at the full picture — because clearing your skin often starts with understanding what's driving the inflammation underneath it.
Sources:
Witkam WCAM, Smak Gregoor AM, van Straalen KR, et al. The shared genetic architecture between acne vulgaris and inflammatory bowel disease: a cross-trait analysis. J Invest Dermatol. Published online April 29, 2026. doi:10.1016/j.jid.2026.03.041
Verstockt B, Salas A, Sands BE, et al. IL-12 and IL-23 pathway inhibition in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2023;20(7):433–446. doi:10.1038/s41575-023-00768-1